Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public Health.

Arya, Vikram; Hodowanec, Aimee C; Troy, Stephanie B; Struble, Kimberly A

Arya, Vikram; Hodowanec, Aimee C; Troy, Stephanie B; Struble, Kimberly A.

Afiliação

Arya V; Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Hodowanec AC; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Troy SB; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Struble KA; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.

Clin Infect Dis ; 75(Suppl 4): S498-S501, 2022 11 21.

Article em En | MEDLINE | ID: mdl-36410378

Assuntos

Infecções por HIV; HIV-1; Humanos; Saúde Pública; Infecções por HIV/tratamento farmacológico; Infecções por HIV/prevenção & controle; Antirretrovirais/uso terapêutico

Palavras-chave

HIV-1 prevention; HIV-1 treatment; antiretroviral therapy; long-acting formulations

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google